Government Appeals Nyan Ruling -Executive challenges Wolokolie’s February 16 ruling

MONROVIA – The Boakai administration has chosen to fight on rather than settle with Dr. Dougbeh Christopher Nyan. The Executive Branch has appealed to the Supreme Court’s full bench against a February 16, 2026 ruling by the Justice in Chambers. That ruling ordered Nyan reinstated as head of the National Public Health Institute of Liberia (NPHIL). Failing that, he was to be paid for his remaining tenure. Arguments open Monday, October 26. The stakes reach beyond one scientist’s job. At issue is whether a President can remove a tenured official without investigation or a hearing. As THE ANALYST reports, Dr. Nyan asks what legal ground remains for the appeal, and the government has yet to explain its case.

The Executive Branch of Government has taken its legal battle with former National Public Health Institute of Liberia (NPHIL) Director General Dr. Dougbeh Christopher Nyan to the full bench of the Supreme Court of Liberia, appealing a February 16, 2026 ruling by the Justice in Chambers that declared his dismissal unlawful.

Argument in the unlawful termination case, Dr. Dougbeh Christopher Nyan v. Executive Branch of Government, is slated for Monday, October 26, 2026, at 11:00 a.m., according to a communication received by THE ANALYST.

Reacting to the appeal, Dr. Nyan insisted that the government “was completely wrong as stated by the Ruling.”

“I made tremendous progress at the NPHIL in just one year. Never accused of any wrongdoing, never charged, never investigated, but unlawfully terminated,” he stated.

He questioned the basis of the Executive’s decision to contest the ruling rather than comply with it.

“So on what legal basis is the Boakai government appealing, instead of reinstatement or compensation for the rest of my tenure?” Dr. Nyan asked.

What the Chambers Ruling Held

In her February 16 ruling, Associate Justice in Chambers Jamesetta Howard Wolokolie granted Dr. Nyan’s petition for a writ of prohibition and ordered the government either to restore him as Director General or to compensate him through the remainder of his statutory five-year tenure, according to published accounts of the decision.

The ruling held that the President’s decision to remove him violated the Constitution because it was carried out without a legally established investigation and without affording the tenured official a proper hearing.

The Court found that the removal was triggered by an NPHIL Board of Directors resolution dated September 12, 2025, which recommended his dismissal on the basis of management complaints but did not reference any investigation.

The Justice also rejected the government’s central defense that an investigation had justified the dismissal, finding that the February 2025 internal report it relied on had already been used to support the Board’s earlier suspension of Dr. Nyan and could not serve as fresh grounds for removal.

In grounding the decision, the Court relied on constitutional due-process protections, including Article 20(a) of the 1986 Constitution, and on the NPHIL Act of 2016, which provides a fixed five-year tenure for the Director General. It also drew on a line of Supreme Court precedent, including Yealue et al. v. Executive Branch of Government, that protects tenured officials in autonomous agencies from summary removal.

Months of Reported Non-Compliance

Dr. Nyan, a medical doctor, biomedical research scientist and inventor, was appointed NPHIL Director General in 2024 and removed by President Joseph Nyuma Boakai on October 15, 2025.

He petitioned the Supreme Court eight days later, on October 23, 2025, arguing that the Board resolution cited no evidence of wrongdoing and that he had been neither accused nor investigated.

Weeks after the February ruling, local media reported that the Court’s mandate had not been implemented, even though the ruling barred the Officer-in-Charge and Acting Director General, Sia Camanor, from performing any functions at NPHIL.

The Ministry of Justice was reported to have advised the Executive Mansion on the implications of the ruling and the legal consequences of non-compliance.

The appeal now places the matter before the full bench, which may affirm, modify or reverse the Chambers ruling. For Dr. Nyan, the question is why the government chose litigation over the two remedies the Court had already laid before it.

Stakes Beyond One Official

Legal analysts have described the Chambers decision as a major setback for the Boakai administration, sharply limiting its power to remove tenured officials without proper investigation and due process, and have said the outcome could shape future disputes over tenured positions across government institutions.

A reversal by the full bench would widen the Executive’s latitude over autonomous agencies, while an affirmation would harden those protections and leave the government facing either Dr. Nyan’s return or the cost of paying him for the balance of his term.

Dr. Nyan has been credited in public health reports with strengthening NPHIL’s technical capacity and leading responses to Mpox, Lassa fever and measles outbreaks, and under his tenure the institute was designated by the Africa Centres for Disease Control and Prevention (Africa CDC) as an Africa Regional Center of Excellence for National Public Health Institute Development.

The Board’s case against him, as recounted in the litigation, centered on management complaints, including claims that he repeatedly failed to involve the Board in critical decision-making.

The Ministry of Justice, which represents the Executive Branch in the matter, has not publicly outlined the grounds of its appeal. Those grounds had not been made public as of press time, and the full bench is expected to hear them for the first time on Monday.